HRTX FY 2019 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$146M+88.4% YoY

Gross Profit

$84M57.8% margin

Operating Income

-$211M-144.3% margin

Net Income

-$205M-140.3% margin

EPS (Diluted)

$-2.50

Cash Flow

Operating Cash Flow

-$125M

Free Cash Flow

-$132M

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$513M

Total Liabilities

$109M

Stockholders' Equity

$404M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$146M	$77M	+88.4%
Gross Profit	$84M	$50M	+68.8%
Operating Income	-$211M	-$184M	-14.5%
Net Income	-$205M	-$179M	-14.5%